Environmental, Social And Governance (ESG) Report

Overview

The report presents TOT BIOPHARM's 2020 performance across oncology R&D, governance, people, and environmental operations. It highlights the TAB008 marketing application and TAA013's Phase III clinical progress, alongside an ESG governance system led by the Board and supported by an ESG working group. Operational disclosures include 368 employees, 3,732 tons of standard coal in total energy consumption, and 12,239 tons of CO2 total GHG emissions.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Publication date: 27 June 2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services